A new dominant selectable marker for use in Cryptococcus neoformans

Medical Mycology

Volumn 39, Issue 1, 2001, Pages 151-154

  McDade, H C ^a   Cox, G M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cryptococcus; Fungus; Nourseothricin; Transformation

Indexed keywords

ACYLTRANSFERASE; CLONNAT; FUNGAL DNA; HYGROMYCIN B; NOURSEOTHRICIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BACTERIUM TRANSFORMATION; BIOLOGICAL MODEL; CRYPTOCOCCUS NEOFORMANS; FUNGAL GENETICS; GENE; GENE EXPRESSION; GENETIC MARKER; GENOME; NONHUMAN; PROMOTER REGION; SEROTYPE; SOUTHERN BLOTTING; STREPTOMYCES;

BACTERIA (MICROORGANISMS); CRYPTOCOCCUS NEOFORMANS; FILOBASIDIELLA NEOFORMANS; FUNGI; STREPTOMYCES; STREPTOMYCES NOURSEI;

EID: 0035119757     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/mmy.39.1.151.154     Document Type: Article

References (16)

1. Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995; 8: 515-548.
2. Arncngou APC. Mascaro J, Garcio-Bragado F. Possible development of resistance to fluconazole during suppressive therapy for AIDS-associated cryptococcal meningitis. Clin Infect Dix 1996; 23: 322-328.
3. Birley HD, McDonald P, Parry C. Carey PB, Warnock DW. Azole drug resistance as a cause of clinical relapse in AIDS patients with cryptococcal meningitis, hit J STD AIDS 1995: 6: 353-355.
4. Edman JC. Kwon-Chung KJ. Isolation of the URA5 gene from Cryptococcus neoformans var. neoformans and its use as a selective marker for transformation. Mot Cell Biol 1990: 10: 4538-4544.
5. Toffaletti DL. Rude TH. Johnston SA. Durack DT, Perfect JR. Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J Bad 1993; 175: 1405-1411.
6. Toffaletti DL, Perfect JR. Study of Cryptococcus neoformans actin gene regulation with a beta-galactosidase-actin fusion. ./ Med Vet Mycol 1997; 35: 313-320.
7. del Poeta M, Toffaletti DL, Rude TH, Sparks SD, Heitman J, Perfect JR. Cryptococcus neoformans differential gene expression detected in vitro and in vivo with green fluorescent protein. Infect Immun 1999; 67: 1812-1820.
8. Cox GM, Toffaletti DL, Perfect JR. Dominant selection system for use in Cryptococcus neoformans. J Med Vet Mycol 1996; 34: 385-391.
9. Sudarshan S, Davidson RC, Alspaugh JA. Molecular analysis of the Cryptococcus neoformans ADE2 gene, a selectable marker for transformation and gene disruption. Fungal Genetics Bio 1999; 27: 3618.
10. Lay J, Henry LK, Clifford J, Koltin Y. Bulawa CE, Becker JM. Altered expression of selectable marker URA3 in genedisrupted Candida albicans strains complicates interpretation of virulence studies. Infect Immun 1998; 66: 5301-5306.
11. Krugel H, Fielder G, Smith C, Baumberg S. Sequence and transcriptional analysis of the nourseothricin acetyltransferaseencoding gene natl from Streptomyces noursei. Gene 1993; 127: 128-131.
12. Gold SE, Bakkeren G, Davis JE, Kronstad JW. Three selectable markers for transformation of Ustilago may dis. Gene 1994; 142: 225-230.
13. Goldstein AL, Pan X, McCusker JH. Heterologous URA3MX cassettes for gene replacement in Saccharomyces cerevisiae. Yeast 1999; 15:507-511.
14. Cox GM, Rude TH, Dykstra CC, Perfect JR. The actin gene from Cryptococcus neoformans: structure and phylogenetic analysis. J Med Vet Mycol 1995; 33: 261-266.
15. Perfect JR. Rude TH, Penning LM, Johnston SA. Cryptococcus neoformans TRP1 gene by complementation in Saccharomyces cerevisiae. Gene 1992; 122: 213-217.
16. Fujimura H, Sakuma Y. Simplified isolation of chromosomal and plasmid DNA from yeasts. Bio Tech 1993; 14: 538-540.